These observations place chemokine pathways such as CXCL1/2–CXCR2, CCL2–CCR2, and IL-8–CXCR1/2—and their downstream effector programs—at the center of immune exclusion in CRC. This evidence concerns the gene CXCL8 and colorectal carcinoma.